| Autoimmune responses to the brain after stroke are associated with worse outcome KJ Becker, AJ Kalil, P Tanzi, DK Zierath, AV Savos, JM Gee, J Hadwin, ... Stroke 42 (10), 2763-2769, 2011 | 135 | 2011 |
| Severe stroke induces long-lasting alterations of high-mobility group box 1 J Schulze, D Zierath, P Tanzi, K Cain, D Shibata, A Dressel, K Becker Stroke 44 (1), 246-248, 2013 | 80 | 2013 |
| CNS immune responses following experimental stroke D Zierath, M Thullbery, J Hadwin, JM Gee, A Savos, A Kalil, KJ Becker Neurocritical care 12, 274-284, 2010 | 71 | 2010 |
| Antibodies to myelin basic protein are associated with cognitive decline after stroke KJ Becker, P Tanzi, D Zierath, MS Buckwalter Journal of neuroimmunology 295, 9-11, 2016 | 61 | 2016 |
| Poststroke fatigue: hints to a biological mechanism K Becker, R Kohen, R Lee, P Tanzi, D Zierath, K Cain, P Mitchell, ... Journal of Stroke and Cerebrovascular Diseases 24 (3), 618-621, 2015 | 60 | 2015 |
| Effects of central oxytocin receptor blockade on water and saline intake, mean arterial pressure, and c-Fos expression in rats DA Fitts, SN Thornton, AA Ruhf, DK Zierath, AK Johnson, RL Thunhorst American Journal of Physiology-Regulatory, Integrative and Comparative …, 2003 | 59 | 2003 |
| Higher plasma fractalkine is associated with better 6-month outcome from ischemic stroke MM Donohue, K Cain, D Zierath, D Shibata, PM Tanzi, KJ Becker Stroke 43 (9), 2300-2306, 2012 | 56 | 2012 |
| Post-stroke infection: a role for IL-1ra? P Tanzi, K Cain, A Kalil, D Zierath, A Savos, JM Gee, D Shibata, J Hadwin, ... Neurocritical care 14, 244-252, 2011 | 50 | 2011 |
| Long term immunologic consequences of experimental stroke and mucosal tolerance JM Gee, D Zierath, J Hadwin, A Savos, A Kalil, M Thullbery, KJ Becker Experimental & translational stroke medicine 1, 1-10, 2009 | 50 | 2009 |
| Cortisol is more important than metanephrines in driving changes in leukocyte counts after stroke D Zierath, P Tanzi, D Shibata, KJ Becker Journal of Stroke and Cerebrovascular Diseases 27 (3), 555-562, 2018 | 42 | 2018 |
| Effects of forebrain circumventricular organ ablation on drinking or salt appetite after sodium depletion or hypernatremia DA Fitts, JA Freece, JE Van Bebber, DK Zierath, JE Bassett American Journal of Physiology-Regulatory, Integrative and Comparative …, 2004 | 42 | 2004 |
| Myelin basic protein autoantibodies, white matter disease and stroke outcome D Shibata, K Cain, P Tanzi, D Zierath, K Becker Journal of neuroimmunology 252 (1-2), 106-112, 2012 | 35 | 2012 |
| Stroke, IL-1ra, IL1RN, Infection and Outcome KJ Becker, D Dankwa, R Lee, J Schulze, D Zierath, P Tanzi, K Cain, ... Neurocritical care 21, 140-146, 2014 | 31 | 2014 |
| Plasma α-melanocyte stimulating hormone predicts outcome in ischemic stroke D Zierath, P Tanzi, K Cain, D Shibata, K Becker Stroke 42 (12), 3415-3420, 2011 | 30 | 2011 |
| Development of a model of status epilepticus in pigtailed macaque infant monkeys VM Gunderson, M Dubach, P Szot, DE Born, HJ Wenzel, KR Maravilla, ... Developmental neuroscience 21 (3-5), 352-364, 1999 | 30 | 1999 |
| Promiscuity of autoimmune responses to MBP after stroke D Zierath, A Kunze, L Fecteau, K Becker Journal of neuroimmunology 285, 101-105, 2015 | 29 | 2015 |
| The immunologic profile of adoptively transferred lymphocytes influences stroke outcome of recipients D Zierath, J Schulze, A Kunze, O Drogomiretskiy, D Nhan, B Jaspers, ... Journal of neuroimmunology 263 (1-2), 28-34, 2013 | 29 | 2013 |
| Peroxiredoxin 5 (PRX5) is correlated inversely to systemic markers of inflammation in acute stroke A Kunze, D Zierath, P Tanzi, K Cain, K Becker Stroke 45 (2), 608-610, 2014 | 28 | 2014 |
| α-MSH: a potential neuroprotective and immunomodulatory agent for the treatment of stroke AV Savos, JM Gee, D Zierath, KJ Becker Journal of Cerebral Blood Flow & Metabolism 31 (2), 606-613, 2011 | 26 | 2011 |
| Splenectomy does not improve long-term outcome after stroke D Zierath, A Shen, A Stults, T Olmstead, KJ Becker Stroke 48 (2), 497-500, 2017 | 25 | 2017 |
